Help us: Donate
Follow us on:
×

Menu

Back

Month: February 2020

The February edition of Journal Club, hosted by Dr. Oliver Medvedik, took a look at a recent paper that explored using gamma stimulation, accomplished through visual and auditory stimuli, to treat Alzheimer's disease. HELP SPREAD THE WORD Please connect with us on social media, like and share our content, and help us build grass-roots support...
Gene editing
The successful delivery of CRISPR/Cas9 modified immune cells to cancer patients represents the first U.S. clinical trial to test the gene editing approach in humans. Researchers from the Abramson Cancer Center of the University of Pennsylvania have published data suggesting that immune cells modified using the gene editing tool CRISPR/Cas9 are able to survive and...
X10 - Only for the Rich?
Veera hosts this informative episode of LifeXtenShow, explaining the accessibility issues of rejuvenation biotechnology and how many people would be helped in a world without it. (Spoiler: That's a small number.) This episode also discusses global poverty and the expenses of drug development. HELP SPREAD THE WORD Please connect with us on social media, like...
Aubrey de Grey on Joe Rogan
Dr. Aubrey de Grey of SENS Research Foundation was interviewed by the extremely popular Joe Rogan, and they discussed the damage repair approach to aging. Dr. de Grey talked about the current state of aging research, including stem cell therapies, and explained the role of SENS in developing next-generation rejuvenation biotechnology therapies. He also brought...
Victor Bjoerk
I grew up in northern Sweden, and from early childhood, I always had a general interest in all kinds of science and technology. I often thought about the future and what sort of society we would evolve into. As far as my memory goes, back even when I was only 3-4 years old, I enjoyed...
Death clock
Recently, researcher Dr. Alexey Moskalev has published a mini review that takes a look at aging biomarkers and how some of them compare with each other [1]. A major challenge in developing therapies that target the aging processes in order to prevent or reverse age-related diseases is having accurate ways to determine if a therapeutic...